EVALUATION OF HYPOGLYCEMIC AND HYPOLIPIDEMIC EFFECTS OF INTERNAL SEPTUM OF WALNUT FRUIT IN ALLOXAN-INDUCED DIABETIC RATS by Ghiravani, Zahra et al.
Ghiravani et al., Afr J Tradit Complement Altern Med. (2016) 13(2):94-100 
http://dx.doi.org/10.4314/ajtcam.v13i2.12 
94 
 
EVALUATION OF HYPOGLYCEMIC AND HYPOLIPIDEMIC EFFECTS OF INTERNAL SEPTUM OF  
WALNUT FRUIT IN ALLOXAN-INDUCED DIABETIC RATS 
 
 
1
Zahra Ghiravani,
 2
 Mehran Hosseini, 
3
Mohamad Mehdi Hassanzadeh Taheri,          
 
4
 Mohammad Hassanpour Fard, 
5,
*Mohammad Reza Abedini 
 
1
Department of physiology, school of Medicine, Birjand University of Medical Sciences (BUMS), Birjand, 
Iran, 
2
Department of public health, Research Centre of Experimental Medicine, BUMS, Birjand, Iran, 
3
Department of Anatomy, BUMS, Birjand, Iran. 
4 
Berberis and Jujube Research Center, Department of Pharmacology, School of Medicine, BUMS, Birjand, 
Iran,  
5
Cellular and Molecular Research Center, Department of Pharmacology, School of Medicine, BUMS, 
Birjand, Iran. 
*Correspondence to: Mohammad Reza Abedini, Mohammad Hassanpour Fard,  
Corresponding Authors E-mails: mohrabe@yahoo.com,  mhassanpour61@yahoo.com 
 
 
 
Abstract 
 
Background: Todays, the popularity of herbal medicine is increasing worldwide. Due to importance the evaluation of medicinal 
herbs efficacy and safety, the present study was conducted to investigate the antidiabetic and hypolipidemic effects of internal 
septum of walnut fruit (ISWF) ethanolic extract in diabetic rats. 
Materials and methods: Alloxan diabetic rats treated orally with ethanolic extract of ISWF (0-400mg/kg) for 28 days. To evaluate 
its anti-diabetic activity, the animals fasting blood glucose were determined on the first, 14th and 29th days. Moreover, oral glucose 
tolerance test (OGTT) was performed in diabetic rats at the last day of the study. After 24h of last administration, the blood samples 
were collected, and the Plasma lipids and liver enzymes levels were measured in fasting overnight rats.   
Results: The extract significantly decreased blood glucose (p<0.001) on 14th and 29th days. In addition, OGTT revealed that the 
hypoglycemic effect of the extract appeared at 90 minutes. Alanine aminotransferase and aspartate aminotransferase levels 
significantly decreased in diabetic rats treated with the both doses (p<0.05). Both doses of the extract were able to decrease 
triglyceride significantly (p<0.05) in treated diabetic rats, while only the lower dose of the extract (200 mg/kg) attenuate the total 
cholesterol and low density lipoprotein (p<0.001). 
Conclusion: These finding support the notion that ISWF is able to reduce hyperglycemia and hyperlipidemia risk in diabetic rats. 
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Introduction 
 
Diabetes mellitus is a chronic metabolic disease characterized by hyperglycemia due to the impaired secretion and/or action of 
insulin (Chikhi et al., 2014). Its prevalence is increasing in many populations all over the world. In 2011, there were 366 million 
cases with diabetes, and it is expected to increase up to 522 million by 2030 (Whiting et al., 2011). Hyperglycemia leads to alteration 
in metabolism of carbohydrate, protein and fat (Wan et al., 2013). This condition results in long term pathogenic disorders such as 
neuropathy, retinopathy and nephropathy and consequently lowering in life quality (Santaguida et al., 2005). Currently, multiple 
pharmacological interventions including sulphonylureas, biguanides, alpha-glucosidase inhibitors, thiazolidinediones and/or insulin 
are applied for the treatment of diabetes (Grossman et al., 2013). However, all of these medications have limited efficacy and result 
in various side effects such as gastrointestinal upset, weight changes, hypoglycemia, joint stiffness, kidney and skin complications 
(Nathan, 2007; Soccio et al., 2014). 
Complementary and alternative medicine has been often used for treatment of diabetes. The most widely used therapies in 
diabetic populations are nutritional supplements and herbal; people with diabetes use these therapies concurrently with conventional 
health care services (Chang et al., 2007). 
The fruit of Juglans regia L (family; Juglandaceae) is a valuable nut largely consumed around the world. Not only dry fruits 
(nuts) but also its green outer pericarp (husks), inner pericarp (shells), barks and leaves have been used in cosmetic and 
pharmaceutical industries (Stampar et al., 2006). The seeds of Juglans regia L. are highly nutritious which have been widely used in 
traditional medicine for treatment of venous insufficiency, hemorrhoid, and diarrhea (Petlevski et al., 2001; Sarahroodi, 2012). In 
Iran, the internal septum of walnut fruit (ISWF) has been traditionally used to treat diabetic patients (Mirheidari, 1995; Zargari, 
1990). However, the impact of Junglans regia septum in diabetes has not been fully elucidated. The present study was conducted to 
evaluate the hypoglycemic and hypolipidemic effects of internal septum of Junglans regia in alloxan-induced diabetic rats. 
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Materials and Methods 
Plant Collection and Extract Preparation 
 
The internal septum of Walnut fruit (ISWF) was purchased from traditional medicine shopkeeper in local market of South 
Khorasan province, Birjand, Iran and confirmed by an expert botanist, and a voucher specimen (721) was assigned by the herbarium 
of Agricultural school  in Birjand University, Birjand, Iran. The ISWF was dried in shade, powdered by electric grinder and then the 
powder was macerated (1:10 w/v) in ethanol 80% at room temperature with occasionally shaking for 2 days. Afterwards, the mixture 
was filtered (Blue Ribbon,Grade 589;Germany), from which 10 ml of the concentrated extract was transferred and dried in a Petri 
dish at  40 °C temperature. The yield of dried extract was about 5% (w/w). 
 
 Total Phenol Assay of the Extract 
 
Phenolic compounds in the ethanolic extract of ISWF were assessed by Folin-Ciocalteu's method (Živković et al., 2009). 
Results were expressed as Means ± Standard Deviation (S.D.) of three parallel replicates for total polyphenol contents. Gallic acid 
was used as a standard and the total phenolics content was expressed as mg/g gallic acid equivalents (GAE). 
 
Chemicals  
 
Alloxan and metformin tablets were purchased from Sigma Aldrich (USA) and Merck Sante' s.a.s., (France), respectively. 
Alloxan and metformin were freshly dissolved in 0.9% normal saline solution for intra-peritoneal (ip) and oral administration 
respectively. 
 
Animals and Experimental Protocol 
 
Male albino Wistar rats with body weight 180-220 g were used in this study. Animals were housed in poly ethylene cages at 
temperature 21-250C, 12 h light/dark cycle and relative air humidity 40-45%. Rats fed at libido with the standard food and tap water. 
The experimental procedure used in the present study approved by the ethic committee of laboratory animal research at Birjand 
University of Medical Sciences. 
 
Induction of Experimental Diabetes 
 
Diabetes was induced in overnight fasted rats using freshly prepared alloxan monohydrate (ip) dissolved in 0.9% saline at a 
single dose (150 mg/kg). After 14 days of injection, the rats with fasting blood sugar (FBS) more than 350 mg/dl were allocated as 
severe diabetic (Etuk, 2010). Similarly, the control group consisting of 8 rats was injected by normal saline 0.9%. 
 
Experimental Designs 
Assessment of ISWF on Alloxan Induced-Diabetic Rats 
 
Thirty two diabetic and 8 normal animals were randomly divided into 5 equal treatment as well as control groups respectively. 
Then the animal groups received treatment as follows:  1: healthy rats (saline 0.9%); 2: diabetic rats (saline 0.9%); 3: diabetic rats 
treated with metformin at 50 mg/kg body weight (b.wt) as positive control; 4 and 5: diabetic rats treated with ethanolic extract of 
ISWF with 200 and 400 mg/kg b.wt respectively. 
The ethanolic extract of ISWF was daily administered for 4 weeks by oral gavage. The blood samples for FBS measurement 
were collected from tail vein at the first (before treatment), 14th and 29th after treatment. The glucose levels were determined using 
ACCU CHEK Active gluco-meter (Germany). 
  
Study on Oral Glucose Tolerance Test (OGTT) 
 
For OGTT assessment, 4 equal groups (n=8) were chosen and orally treated for 28 days (daily) as follows: 1) healthy rats 
with saline 0.9%. as normal control, 2) diabetic rats with 50 mg/kg metformin as positive control, 3 and 4) diabetic rats with 200 mg 
and 400 mg/kg of ISWF as intervention.  OGTT was performed in overnight fasted (18 h) rats. After 30 min of treatment, all the 
groups were orally loaded with 3 g/kg of glucose. Blood samples were collected 0-120 minutes after glucose loading. Blood glucose 
levels were measured using ACCU CHEK Active glucose oxidase-peroxidase reactive strips (Germany). 
 
Effects of ISWF on Lipid Profile and Liver Enzymes  
 
On 29th day, after 24h of last administration, fasted overnight rats were anesthetized and blood samples were drawn from 
heart. Lipid profile; total cholesterol, triglyceride (TG), high density lipoprotein cholesterol (HDL-c), low density lipoprotein 
cholesterol (LDL-c) and liver enzymes; aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were assessed using 
Pars Azmoon standard kits (Iran) and Liasys Random Access AMS auto-analyzer (Italy). 
 
Statistical Analysis 
 
All the data were expressed as mean ± S.D. Data were analyzed by SPSS software (version 16) using ANOVA and tukey 
post hoc test and the difference were considered significant at p<0.05. 
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Results 
Total Polyphenol Contents 
 
Although internal septum of walnut fruit (ISWF) has been traditionally used to treat diabetes, its influence in metabolic 
disorders has not been fully investigated. To examine the effect of ISWF on metabolic disorders, we first measured the total 
polyphenol content of its ethanolic extract and showed that each gram of dried extract contained 21.64 ± 1.44mg GAE/g. 
 
Hypoglycemic Effects of ISWF on Alloxan Induced-Diabetic Rats 
 
We next analyzed the effect of ISWF on FBS concentration in alloxan-induced diabetic animals. As it is shown in Fig. 1, 
on the first day before any treatment, there was a significant increase as much as 4-5 times on FBS levels in experimental groups 
which received alloxan in comparison with control (healthy) group. After 14 days of alloxan administration, ISWF extract 
significantly decreased blood glucose levels in a dose-dependent manner in comparison to diabetic control rats (p<0.05). Metformin 
(50 mg/kg, as a positive control) also significantly decreased FBS level (p<0.05). On the 29th day, both doses of the extract and 
metformin were able to decrease FBS level significantly in diabetic rats when compared with diabetic control group (p<0.05). This 
response in the extract groups were more than metformin group on 14th and 29th days; however, these differences were not 
significant (p>0.05). 
 
 
 
Figure 1: Internal septum of walnut fruit (ISWF) exerts anti-diabetic activity in alloxan-induced severe diabetic rats. Animals were 
treated with normal saline 0.9% as a vehicle (Healthy and diabetic control groups), metformin (50 mg/kg body weight, as positive 
control) and ethanolic extract of ISWF (200 and 400 mg/kg body weight). FBS levels were measured on the 1st, 14th and 29th days 
using a glucometer. Each column represents mean ± S.D, for 8 rats.† P<0.001 compared with diabetic control group. 
 
Effect of Ethanolic Extract of ISWF in OGTT in Normal Rats 
 
To examine hypoglycemic efficacy of ISWF, OGTT was performed in diabetic rats. Table 1 shows the blood glucose 
levels (BGL) of the control, Metformin (50mg/kg) and ethanolic extracts of ISWF (200 mg and 400mg/kg) at different time points 
(0, - 120 min). While oral glucose loading (3g/kg) significantly increased BGL in diabetic rats with a peak at 30 min, ISWF 
dramatically restored glucose levels to normal status in 90 and 120min at concentrations of 400 and 200mg/kg respectively. These 
responses were dose-dependent and comparable with metformin.  
 
Table 1: Effect of ISWF in oral glucose tolerance in diabetic rats 
S.N0 Group (treatment) Blood glucose level mg/dl (Mean ± SD) 
  fasting Post treatment 
30 min 60 min 90 min 120 min 
1 Control (saline0.9%) 82.58 ± 3.65 86.66 ± 4.22 84.38 ± 1.25 85.65 ± 1.01 84.63 ± 3.68 
2 
Metformin (50mg/kg) + glucose 
79.46 ± 2.13 
* 
199.85 ± 4.29 
* 
155.43 ± 3.62 
* 
105.54 ± 4.25 81.8 ± 3.81 
3 
ISWF(200mg/kg) + glucose 
81.23 ± 2.81 
* 
201.67 ± 2.51 
* 
154.28 ± 3.17 
* 
100.97 ± 1.99 92.17 ± 1.21 
4 
ISWF(400mg/kg) + glucose 
79.69 ± 3.89 
* 
193.23 ± 1.93 
* 
143.78 ± 2.32 
 
93.21 ± 2.44 78.21 ± 0.89 
Values are expressed as mean ± SD. ANOVA followed by Tukey test. * P ≤ 0.05 compared normal control group 
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Effects of ISWF on Lipid Profile and Liver Enzymes  
 
 To examine the effect of ISWF on the liver enzyme activity, the above experiment extended to assess the effect of ISWF  
extract on plasma AST and ALT levels in diabetic rats. As shown in Fig. 2, the plasma levels of AST and ALT increased 
significantly in diabetic rats when compared with healthy group after 29 days. Administration of 200 and 400 mg/kg body weight of 
ISWF ethanolic extract dramatically decreased AST in a dose-dependent manner (p=0.013 and p=0.025, respectively) and ALT 
(p<0.001) in comparison to diabetic control group. Although administration of metformin at the dose of 50mg/kg body weight did 
not alter AST (p=0.058), it significantly reduced ALT in comparison to diabetic group (p<0.001). 
         As it is shown in Figure 3, the plasma total cholesterol, triglyceride and LDL-c significantly increased in diabetic rats in 
comparison to healthy control rats. The ISWF extract significantly decreased total cholesterol (p<0.001), TG (p=0.001) and LDL-c 
(p<0.001) at the dose of 200 mg/kg compared with diabetic rats. At the dose of 400 mg/kg, the extract only dramatically decreased 
TG level (p=0.017), while metformin did not significantly alter any of the elevated parameters.  
 
 
Figure 2: ISWF decreases plasma aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in diabetic rats.  Animals 
were treated with normal saline 0.9% as a vehicle (Healthy and diabetic control groups), metformin (50 mg/kg body weight, as 
positive control) and ethanolic extract of ISWF (200 and 400 mg/kg body weight). AST (Fig, 2A) and ALT (Fig, 2B) levels were 
assessed at 29th day. Each column represents mean ± S.D, for 8 rats. † p<0.05 and †† p<0.001compared with diabetic control group. 
 
 
Figure 3: Oral administration of ethanolic extract of ISWF attenuates plasma lipid profile in diabetic rats. Animals were treated with 
ethanolic extract of ISWF (200 and 400 mg/kg body weight), normal saline 0.9% as a vehicle (Healthy and diabetic control groups) 
and metformin (50 mg/kg body weight, as positive control). Total cholesterol, triglyceride (TG), high density lipoprotein cholesterol 
(HDL-c) and low density lipoprotein (LDL-c) were analyzed on the 29thdaysin diabetic rats. Each column represents mean ±S.D. for 
8 rats.       † p<0.05 and †† p<0.001 different from control group. 
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Discussion 
 
 We have studied the influence of ISWF extract on metabolic disorders and demonstrated that it significantly decreased the 
serum levels of a) blood glucose in a dose-dependent manner, b) AST and ALT liver enzymes, and c) total cholesterol, TG and 
LDL-c in alloxan-induced diabetes when compared with diabetic control rats.  
          Diabetes can be induced by pharmacological, surgical or genetic manipulation in several animal species. The most 
experiments on diabetes were carried out in rodents (Eddouks et al., 2012; Shirwaikar et al., 2006). The majority of studies have 
applied pharmacological models in which streptozotocin or alloxan most frequently have been used for diabetes induction 
(Shirwaikar et al., 2006). Both drugs exert their diabetogenic action through reactive oxygen species, which cause rapid destruction 
of pancreatic β-cells(Szkudelski, 2001). In the present study, alloxan has been used to induce diabetes in animal as reported 
previously (Etuk, 2010). 
The ethanolic extract of ISWF significantly decreased glucose level in treated diabetic rats as compared with control group 
(Fig. 1). Anti-hyperglycemic activity of ISWF may be due to presence of polyphenolic compounds in high level (21.65 ± 1.44mg 
GAE/g). The other studies shown that several antidiabetic plants have high levels of polyphenols (El-Demerdash et al., 2005; Jelodar 
et al., 2005) such as; garlic (17.38mg/g), onion (22.32 mg/g) and fenugreek (198 mg/g) (Cheng et al., 2013; Lu et al., 2011; 
SEASOTIYA et al., 2014). Polyphenol has also improved insulin–dependent glucose uptake in muscle cells and adipocytes by 
translocation of glucose transporter, GLUT4, to plasma membrane mainly through induction of the AMP-activated protein kinase 
(AMPK) pathway(Park et al., 2007; Zhang et al., 2011).  AMPK, an important sensor of cellular energy status, has a key role in 
metabolic control through the activation of this pathway and is considered as a new treatment for obesity, diabetes, metabolic 
syndrome and main target for anti-diabetic drugs including metformin (Kumar et al., 2009; Zang et al., 2006). Polyphenols also 
inhibit α-glucosidase and α-amylase, the enzymes responsible for digestion of dietary carbohydrate to glucose (Tadera et al., 2006). 
Plant-food polyphenols have been shown to attenuate hepatic gluconeogenesis via decreasing the activity of glucose-6-phosphatase 
and phosphoendolpyruvate carboxykinase (PEPCK) and down regulation of liver glucokinase expression (Waltner-Law et al., 2002). 
Several studies have shown that polyphenol compounds protect β-cells from oxidative-induced damages by enhancing the natural 
antioxidant system, inhibition of lipid peroxidation and stimulation on the β-cells (Szkudelski, 2007; Szkudelski and Szkudelska, 
2011). These suggest that the possible mechanisms for antidiabetic action of ISWF may be due to stimulation of peripheral glucose 
uptake in tissues, modulation of carbohydrate metabolism and attenuation of intestinal absorption for dietary carbohydrate. Also it 
may act by increasing the insulin secretion from the existing pancreatic β cells. To our knowledge, this is the first report that shows 
ISWF completely reduce elevated glucose serum level in diabetic rats to normal value. 
Our finding also showed that ISWF significantly prevented the elevated AST and ALT serum levels in treated diabetic rats as 
compared with control group. These enzymes are usually found in large quantities in the liver where they play an important role in 
the metabolism of amino acids (Yin et al., 2011).  Due to damage or toxicity to the liver (e.g. in diabetic patients), these enzymes 
may leak from the hepatocytes into the circulation, and lead to elevation in blood (Carobene et al., 2013; Coballase-Urrutia et al., 
2011). In our study similar to the several other studies with different duration (2-8 weeks) and various diabetogenic drugs (alloxan or 
streptozotocin), AST and ALT significantly elevated in diabetic rats in comparison with control ones(Aloulou et al., 2012; Erejuwa 
et al., 2012; Karthik and Ravikumar, 2011; Saeed et al., 2008). Interestingly, ISWF not only prevented the elevation of enzyme 
levels in diabetic rats but also restored their levels to normal values (Fig. 2). In the other study, oral administration of Walnut extract 
significantly reduced serum glutamic oxaloacetic transaminase (AST) and glutamic pyruvic transaminase (ALT) in injured liver 
induced by carbon tetrachloride (CCl4) in mice(Shimoda et al., 2009). 
Since lipid abnormalities are the major causes of cardiovascular diseases in diabetic patients, ideal treatment for diabetes (in 
addition to glycemic control) should have a favorable effect on lipid profile. The various types of oral anti-diabetic drugs, currently 
approved for the treatment of type 2 diabetes do not have a desire effects on cardiovascular disease(Fisman et al., 2008). while most 
of anti-hypercholesterolemic drugs do not decrease TG levels (El-Hazmi and Warsy, 2001), the ethanolic extract of ISWF in both 
doses prevented the elevation of plasma TG level after 28 days of administration (Fig. 3). In terms of total cholesterol and LDL-c 
levels, IWSF at the dose of 200 mg/kg significantly reduced these values after 28 days of treatment. Other studies also shown that 
walnut diet reduced the levels of, LDLc, and HDLc, total cholesterol as well as the ratio of LDL cholesterol to HDL 
cholesterol(Sabate et al., 1993; Tapsell et al., 2004). Walnut also has been reported to have several phytosterol compounds which are 
able to inhibit intestinal absorption of cholesterol (Amaral et al., 2003). Oral administration of walnut polyphenol significantly 
reduced liver and serum triglycerides (Shimoda et al., 2009). The lipid lowering effect of the extract might be due to the action of 
flavanoids and other phenolic compounds. The plant polyphenols reduce cholesterol level by inhibiting 3-hydroxy-3-methyl-glutaryl 
Coenzyme A reductase (HMG CoA reductase), the rate-regulatory enzyme of cholesterol biosynthesis (Sharma et al., 2003). 
Moreover, it was shown that some polyphenols such as tri-terpenoids can decrease TG levels by activated lipoprotein lipase enzymes 
(Kamanyi et al., 1994).  
In summary, the ethanolic extract of ISWF exhibits strong hypoglycemic and hypolipidemic activity in diabetic rats. The 
ISWF extract potentially can be considered as a hypoglycemic agent. It also alleviates the dyslipidemia parameters, thereby 
preventing the cardiovascular complications which are common in diabetic patients associated with diabetes. 
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